Metabolically driven maturation of human-induced-pluripotent-stem-cell-derived cardiac microtissues on microfluidic chips

[1]  Evan W. Miller,et al.  Heart Muscle Microphysiological System for Cardiac Liability Prediction of Repurposed COVID-19 Therapeutics , 2021, Frontiers in Pharmacology.

[2]  Evan W. Miller,et al.  In vitro safety “clinical trial” of the cardiac liability of drug polytherapy , 2021, Clinical and translational science.

[3]  Wesley L. McKeithan,et al.  Metabolic Maturation Media Improve Physiological Function of Human iPSC-Derived Cardiomyocytes , 2020, Cell reports.

[4]  A. Tveito,et al.  Computational prediction of drug response in short QT syndrome type 1 based on measurements of compound effect in stem cell-derived cardiomyocytes , 2020, bioRxiv.

[5]  A. Tveito,et al.  Identifying Drug Response by Combining Measurements of the Membrane Potential, the Cytosolic Calcium Concentration, and the Extracellular Potential in Microphysiological Systems , 2020, bioRxiv.

[6]  Karoline Horgmo Jæger,et al.  Improved Computational Identification of Drug Response Using Optical Measurements of Human Stem Cell Derived Cardiomyocytes in Microphysiological Systems , 2019, bioRxiv.

[7]  A. Tveito,et al.  Detecting undetectables: Can conductances of action potential models be changed without appreciable change in the transmembrane potential? , 2019, Chaos.

[8]  Joe Z. Zhang,et al.  Human-Induced Pluripotent Stem Cell Model of Trastuzumab-Induced Cardiac Dysfunction in Patients With Breast Cancer. , 2019, Circulation.

[9]  Joe Z. Zhang,et al.  A Human iPSC Double-Reporter System Enables Purification of Cardiac Lineage Subpopulations with Distinct Function and Drug Response Profiles. , 2019, Cell stem cell.

[10]  Marc Santolini,et al.  The Ca2+ transient as a feedback sensor controlling cardiomyocyte ionic conductances in mouse populations , 2018, eLife.

[11]  Costas P. Grigoropoulos,et al.  Contractile deficits in engineered cardiac microtissues as a result of MYBPC3 deficiency and mechanical overload , 2018, Nature Biomedical Engineering.

[12]  A. Tveito,et al.  Inversion and computational maturation of drug response using human stem cell derived cardiomyocytes in microphysiological systems , 2018, bioRxiv.

[13]  K. Campbell,et al.  Sarcolipin Makes Heat, but Is It Adaptive Thermogenesis? , 2018, Front. Physiol..

[14]  Gordana Vunjak-Novakovic,et al.  Advanced maturation of human cardiac tissue grown from pluripotent stem cells , 2018, Nature.

[15]  D. Strauss,et al.  Comparative analysis of media effects on human induced pluripotent stem cell-derived cardiomyocytes in proarrhythmia risk assessment. , 2018, Journal of pharmacological and toxicological methods.

[16]  S. Yajima,et al.  Pivotal Role of Non-cardiomyocytes in Electromechanical and Therapeutic Potential of Induced Pluripotent Stem Cell-Derived Engineered Cardiac Tissue , 2017, Tissue engineering. Part A.

[17]  J. Nerbonne,et al.  Differential Expression and Remodeling of Transient Outward Potassium Currents in Human Left Ventricles , 2018, Circulation. Arrhythmia and electrophysiology.

[18]  B. Knollmann,et al.  Thyroid and Glucocorticoid Hormones Promote Functional T-Tubule Development in Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes , 2017, Circulation research.

[19]  N. Bursac,et al.  Cardiopatch platform enables maturation and scale-up of human pluripotent stem cell-derived engineered heart tissues , 2017, Nature Communications.

[20]  R. Passier,et al.  A COUP-TFII Human Embryonic Stem Cell Reporter Line to Identify and Select Atrial Cardiomyocytes , 2017, Stem cell reports.

[21]  H. Kimura,et al.  Pumpless microfluidic system driven by hydrostatic pressure induces and maintains mouse spermatogenesis in vitro , 2017, Scientific Reports.

[22]  David E James,et al.  Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest , 2017, Proceedings of the National Academy of Sciences.

[23]  Cassady E Rupert,et al.  IGF1 and NRG1 Enhance Proliferation, Metabolic Maturity, and the Force-Frequency Response in hESC-Derived Engineered Cardiac Tissues , 2017, Stem cells international.

[24]  Ana P. Teixeira,et al.  Distinct carbon sources affect structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells , 2017, Scientific Reports.

[25]  G. Keller,et al.  Human Pluripotent Stem Cell-Derived Atrial and Ventricular Cardiomyocytes Develop from Distinct Mesoderm Populations. , 2017, Cell stem cell.

[26]  H. Reichenspurner,et al.  Human iPSC-derived cardiomyocytes cultured in 3D engineered heart tissue show physiological upstroke velocity and sodium current density , 2017, Scientific Reports.

[27]  Andrew W. Trafford,et al.  Calcium and Excitation-Contraction Coupling in the Heart , 2017, Circulation research.

[28]  M. Goumans,et al.  Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair , 2017, Circulation.

[29]  Lil Pabon,et al.  In Vivo Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Neonatal and Adult Rat Hearts , 2017, Stem cell reports.

[30]  P. Crouch,et al.  Circumventing the Crabtree Effect: A method to induce lactate consumption and increase oxidative phosphorylation in cell culture. , 2016, The international journal of biochemistry & cell biology.

[31]  Michael P Snyder,et al.  Transcriptome Profiling of Patient-Specific Human iPSC-Cardiomyocytes Predicts Individual Drug Safety and Efficacy Responses In Vitro. , 2016, Cell stem cell.

[32]  Steven C George,et al.  Three-Dimensional Adult Cardiac Extracellular Matrix Promotes Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. , 2016, Tissue engineering. Part A.

[33]  Herbert Schulz,et al.  Human Engineered Heart Tissue: Analysis of Contractile Force , 2016, Stem cell reports.

[34]  Xuetao Sun,et al.  Biowire platform for maturation of human pluripotent stem cell-derived cardiomyocytes. , 2016, Methods.

[35]  Kevin E. Healy,et al.  Miniaturized iPS-Cell-Derived Cardiac Muscles for Physiologically Relevant Drug Response Analyses , 2016, Scientific Reports.

[36]  E. Andreu,et al.  Line Generation and characterization of human iPSC line generated from mesenchymal stem cells derived from adipose tissue , 2015 .

[37]  S. Severi,et al.  Human induced pluripotent stem cell‐derived versus adult cardiomyocytes: an in silico electrophysiological study on effects of ionic current block , 2015, British journal of pharmacology.

[38]  J. Hancox,et al.  Molecular basis of hERG potassium channel blockade by the class Ic antiarrhythmic flecainide , 2015, Journal of molecular and cellular cardiology.

[39]  George Church,et al.  Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy , 2015, Science.

[40]  Evan W. Miller,et al.  A Photostable Silicon Rhodamine Platform for Optical Voltage Sensing. , 2015, Journal of the American Chemical Society.

[41]  Eva Wagner,et al.  Physiologic force-frequency response in engineered heart muscle by electromechanical stimulation. , 2015, Biomaterials.

[42]  Gordon Keller,et al.  Mechanical Stress Promotes Maturation of Human Myocardium From Pluripotent Stem Cell‐Derived Progenitors , 2015, Stem cells.

[43]  Kavitha T. Kuppusamy,et al.  Let-7 family of microRNA is required for maturation and adult-like metabolism in stem cell-derived cardiomyocytes , 2015, Proceedings of the National Academy of Sciences.

[44]  A. Salis,et al.  The molecular motion of bovine serum albumin under physiological conditions is ion specific. , 2015, Chemical communications.

[45]  Luke P. Lee,et al.  Human iPSC-based Cardiac Microphysiological System For Drug Screening Applications , 2015, Scientific Reports.

[46]  Nathaniel Huebsch,et al.  Automated Video-Based Analysis of Contractility and Calcium Flux in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Cultured over Different Spatial Scales. , 2015, Tissue engineering. Part C, Methods.

[47]  Sean P. Palecek,et al.  Efficient Differentiation of Human Pluripotent Stem Cells to Endothelial Progenitors via Small-Molecule Activation of WNT Signaling , 2014, Stem cell reports.

[48]  K. Tepp,et al.  Formation of highly organized intracellular structure and energy metabolism in cardiac muscle cells during postnatal development of rat heart. , 2014, Biochimica et biophysica acta.

[49]  G. Fishman,et al.  Identification and Purification of Human Induced Pluripotent Stem Cell-Derived Atrial-Like Cardiomyocytes Based on Sarcolipin Expression , 2014, PloS one.

[50]  Kevin E. Healy,et al.  Calcium Transients Closely Reflect Prolonged Action Potentials in iPSC Models of Inherited Cardiac Arrhythmia , 2014, Stem cell reports.

[51]  H. Ruohola-Baker,et al.  Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells. , 2014, Journal of molecular and cellular cardiology.

[52]  K. Healy,et al.  Controlling Osteogenic Stem Cell Differentiation via Soft Bioinspired Hydrogels , 2014, PloS one.

[53]  George A. Truskey,et al.  Modeling the mitochondrial cardiomyopathy of Barth syndrome with iPSC and heart-on-chip technologies , 2014, Nature Medicine.

[54]  Jae-Ho Kim,et al.  Multiple pathways are involved in palmitic acid-induced toxicity. , 2014, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[55]  Donald M Bers,et al.  Screening Drug-Induced Arrhythmia Using Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes and Low-Impedance Microelectrode Arrays , 2013, Circulation.

[56]  Stefan R. Pulver,et al.  Ultra-sensitive fluorescent proteins for imaging neuronal activity , 2013, Nature.

[57]  Wei-Zhong Zhu,et al.  Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. , 2013, Stem cells and development.

[58]  Nenad Bursac,et al.  Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. , 2013, Biomaterials.

[59]  Donald M Bers,et al.  Drug Screening Using a Library of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity , 2013, Circulation.

[60]  遠山 周吾.  Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes , 2013 .

[61]  Yvonne Will,et al.  Characterization of human-induced pluripotent stem cell-derived cardiomyocytes: bioenergetics and utilization in safety screening. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[62]  S. Priori,et al.  Inherited calcium channelopathies in the pathophysiology of arrhythmias , 2012, Nature Reviews Cardiology.

[63]  Fu Siong Ng,et al.  Processing and analysis of cardiac optical mapping data obtained with potentiometric dyes. , 2012, American journal of physiology. Heart and circulatory physiology.

[64]  Y. Xiang,et al.  Palmitoylation Regulates Intracellular Trafficking of β2 Adrenergic Receptor/Arrestin/Phosphodiesterase 4D Complexes in Cardiomyocytes , 2012, PloS one.

[65]  Amrita X. Sarkar,et al.  Exploiting mathematical models to illuminate electrophysiological variability between individuals , 2012, The Journal of physiology.

[66]  Sean P. Palecek,et al.  Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling , 2012, Proceedings of the National Academy of Sciences.

[67]  Euan A. Ashley,et al.  Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial Dilated Cardiomyopathy , 2012, Science Translational Medicine.

[68]  J. Scannell,et al.  Diagnosing the decline in pharmaceutical R&D efficiency , 2012, Nature Reviews Drug Discovery.

[69]  Jürgen Hescheler,et al.  Organotypic slice culture from human adult ventricular myocardium. , 2012, Cardiovascular research.

[70]  James A Thomson,et al.  High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. , 2011, American journal of physiology. Heart and circulatory physiology.

[71]  Wolfgang A. Linke,et al.  Terminal Differentiation, Advanced Organotypic Maturation, and Modeling of Hypertrophic Growth in Engineered Heart Tissue , 2011, Circulation research.

[72]  Charles E. Murry,et al.  Growth of Engineered Human Myocardium With Mechanical Loading and Vascular Coculture , 2011, Circulation research.

[73]  E. Aliot,et al.  Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[74]  N. Ishizaka,et al.  Three-dimensional architecture of cardiomyocytes and connective tissue in human heart revealed by scanning electron microscopy. , 2010, Circulation.

[75]  Jian Yang,et al.  The ß subunit of voltage-gated Ca2+ channels. , 2010, Physiological reviews.

[76]  G. Lopaschuk,et al.  Energy Metabolic Phenotype of the Cardiomyocyte During Development, Differentiation, and Postnatal Maturation , 2010, Journal of cardiovascular pharmacology.

[77]  C. Rueden,et al.  Metadata matters: access to image data in the real world , 2010, The Journal of cell biology.

[78]  David W Piston,et al.  Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass. , 2010, Journal of molecular and cellular cardiology.

[79]  Roberto Brunelli,et al.  Template Matching Techniques in Computer Vision: Theory and Practice , 2009 .

[80]  D. Roden,et al.  Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans , 2009, Nature Medicine.

[81]  Sean P. Palecek,et al.  Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells , 2009, Circulation research.

[82]  Wei Zheng,et al.  Chemical calcium indicators. , 2008, Methods.

[83]  Tianen Yang,et al.  Alfuzosin Delays Cardiac Repolarization by a Novel Mechanism , 2008, Journal of Pharmacology and Experimental Therapeutics.

[84]  M. Gore,et al.  The Presence of Sarcolipin Results in Increased Heat Production by Ca2+-ATPase* , 2006, Journal of Biological Chemistry.

[85]  Wolfram-Hubertus Zimmermann,et al.  Optimizing Engineered Heart Tissue for Therapeutic Applications as Surrogate Heart Muscle , 2006, Circulation.

[86]  Sheryl E. Koch,et al.  The L-type calcium channel in the heart: the beat goes on. , 2005, The Journal of clinical investigation.

[87]  L. S. Fridericia,et al.  The Duration of Systole in an Electrocardiogram in Normal Humans and in Patients with Heart Disease * , 2003, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[88]  A. Camm,et al.  Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. , 2003, Cardiovascular research.

[89]  Kevin E Healy,et al.  Sequential robust design methodology and X-ray photoelectron spectroscopy to analyze the grafting of hyaluronic acid to glass substrates. , 2002, Journal of biomedical materials research.

[90]  W. Zimmermann,et al.  Tissue Engineering of a Differentiated Cardiac Muscle Construct , 2002, Circulation research.

[91]  J. East,et al.  Sarcolipin uncouples hydrolysis of ATP from accumulation of Ca2+ by the Ca2+-ATPase of skeletal-muscle sarcoplasmic reticulum. , 2002, The Biochemical journal.

[92]  B. Stephens.  The Beat Goes On , 1991, Science.

[93]  Donald M. Bers,et al.  Excitation-Contraction Coupling and Cardiac Contractile Force , 1991, Developments in Cardiovascular Medicine.

[94]  J. Naim,et al.  The effect of molecular weight and gel preparation on humoral adjuvancy of silicone oils and silicone gels. , 1995, Immunological investigations.

[95]  Khosrow Dehnad,et al.  Quality Control, Robust Design, and the Taguchi Method , 1989 .

[96]  P. Freedson,et al.  Scientific Statement From the American Heart Association Guide to the Assessment of Physical Activity: Clinical and Research Applications: A , 2015 .